Yongwei Wu is a highly skilled scientist with significant experience in organic chemistry and process development. Background includes a Ph.D. from Brandeis University, where a novel bioinspired asymmetric synthesis of trifluoromethylated amines was discovered and optimized. Work experience includes a postdoctoral fellowship at The Scripps Research Institute, focusing on catalytic asymmetric Umpolung reactions, and a previous role as a research associate with advancements in Pd-catalyzed reactions. As a scientist at Amgen from November 2017 to December 2019, Yongwei contributed to a CNS-target project team, and currently serves as a Process Development Scientist. Educational credentials also include a Bachelor of Science from Tsinghua University and a short course in medicinal chemistry from Drew University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices